The below Parliamentary question was asked by Lord Freyberg on 2016-02-08.
To ask Her Majesty’s Government, further to the Written Answer by Lord Prior of Brampton On 4 February (HL5341), what consideration the NHS has given to offering to share outcome data with test providers, where suitable consents can be captured, on the forthcoming re-procurement of the NHS regional genetics labs, such as from the National Cancer Intelligence Network; and what assessment they have made of the impact of doing so on their procurement process, in the light of the experience of Genomic Enterprise.
Baroness Anelay of St Johns
The Secretary of State for Foreign and Commonwealth Affairs, my right Hon. Friend the Member for Runnymede and Weybridge (Mr Hammond), strongly condemned the Democratic People’s Republic of Korea (DPRK)’s satellite launch of 7 February, which used ballistic missile technology in clear violation of a number of UN Security Council Resolutions. On 8 February the Minister of State for Foreign and Commonwealth Affairs, my right hon. Friend the Member for East Devon (Mr Swire), summoned the DPRK’s Ambassador to make clear the UK’s strong condemnation of the launch. The DPRK’s actions are a further threat to regional security and the stability of the Korean peninsula. It is clear that the DPRK continues to prioritise its nuclear and ballistic missile programmes over the welfare of its people.
We continue to work closely with other members of the UN Security Council to ensure significant and substantive measures are agreed in response to the DPRK’s provocations. On 8 February the Prime Minister, my right Hon. Friend the Member for Witney (Mr Cameron), and the Foreign Secretary raised this with the Chinese Ambassador and reiterated the need for progress on a new UN Resolution.
We are not part of discussions with the Republic of Korea on a missile defence system, but we respect and support our allies’ need to defend themselves.
